Get an email when this journal's indexing changes
Added to or removed from Scopus, Web of Science, ABDC, DOAJ, FT50, UT Dallas or ONOS. One confirmation click; unsubscribe anytime.
Engineered Regeneration is Scopus-indexed (Q1, CiteScore 18.4), DOAJ. It is covered by India's One Nation One Subscription scheme, which pays the article processing charge for authors at eligible institutions. Published by KeAi Communications Co..
Checked against the index lists dated .
ISSN 2666-1381Verify ISSN ↗
Publisher: KeAi Communications Co.
Cost to publish: APC covered for authors at ONOS-subscribed Indian institutions
| Subject area | Rank | Pctile | Q |
|---|---|---|---|
| Medicine (miscellaneous) | 10 / 466 | 97th | Q1 |
| Biomedical Engineering | 18 / 342 | 94th | Q1 |
| Biomaterials | 11 / 146 | 92nd | Q1 |
Not listed in: Web of Science, ABDC, ABS / AJG, FT50, UT Dallas, ONOS (subscription)
Yes — actively indexed in Scopus, coverage 2020–present, best quartile Q1, CiteScore 18.4.
Engineered Regeneration is Q1 in Medicine (miscellaneous) (rank 10 of 466), Q1 in Biomedical Engineering (rank 18 of 342) and Q1 in Biomaterials (rank 11 of 146), by CiteScore 2025.
Engineered Regeneration is not in the Web of Science Core Collection (SCIE, SSCI, AHCI or ESCI), so Clarivate publishes no Journal Impact Factor for it. Its Scopus CiteScore is 18.4, quartile Q1, 97th percentile. Any "impact factor" quoted elsewhere is not the Clarivate metric. Its SCImago Journal Rank (SJR, a free Scopus-based metric) is 1.202, quartile Q1, with an H-index of 44.
For authors at Indian institutions covered by One Nation One Subscription (ONOS), the article processing charge is paid by the scheme. The publisher lists an article processing charge of about US$700 for open access (source: OpenAlex). Many journals also publish by the subscription route at no cost to the author, so confirm on the journal's own website.
Engineered Regeneration is published by KeAi Communications Co. Its ISSN is 2666-1381.
Yes. ONOS also covers its article processing charge for authors at eligible institutions.
No — it is not currently in the Web of Science core collections (SCIE, SSCI, AHCI or ESCI).
Yes — it is an open-access journal, listed in DOAJ.
Engineered Regeneration has an h-index of 46 and a 2-year mean of 4.51 citations per paper (OpenAlex). Its Scopus CiteScore is 18.4, quartile Q1. On 2-year citations it ranks #58 of 451 Scopus journals in Medicine (miscellaneous).
Engineered Regeneration published 19 papers in 2025; its busiest recent year was 2022 with 47. 2026* is the year so far.
h-index, i10-index and 2-year mean citedness are open, licence-clear metrics from OpenAlex — not a proprietary impact factor. The subject rank counts only journals that OpenAlex has a figure for; it is not a Scopus or Clarivate ranking. Updated 2026-10-14.
In its latest 96 research articles (2023–2026), authors are most often from China (57%), United States (10.6%) and India (6%). More than half of recent authorship comes from one country.
Countries are counted fractionally, so a paper by authors from two countries counts half to each.
Scopus status: Active. No retracted papers are recorded. The Problematic Paper Screener flags none of its papers. These are indicators to check, not findings against the journal.
Retractions from OpenAlex; flags from the Problematic Paper Screener (Cabanac, Labbé & Magazinov, CC BY), 2026-09-21 export. A flag marks a paper for a closer look; it is not a finding against the journal.
Index data is curated from public sources (Scopus, Web of Science, ABDC, FT50, UT Dallas, DOAJ). CiteScore and quartiles reflect the latest available Scopus release. Always verify a journal's current status on its official source before submitting.
Comments load as you scroll here.